- Home
- PYPD vs CVR Comparison
PYPD vs CVR Comparison
Compare PYPD & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- CVR
- Stock Information
- Founded
- PYPD 2008
- CVR 1920
- Country
- PYPD Israel
- CVR United States
- Employees
- PYPD N/A
- CVR N/A
- Industry
- PYPD Medical/Dental Instruments
- CVR Industrial Machinery/Components
- Sector
- PYPD Health Care
- CVR Industrials
- Exchange
- PYPD Nasdaq
- CVR Nasdaq
- Market Cap
- PYPD 19.4M
- CVR 15.7M
- IPO Year
- PYPD 2020
- CVR N/A
- Fundamental
- Price
- PYPD $3.30
- CVR $15.50
- Analyst Decision
- PYPD Strong Buy
- CVR
- Analyst Count
- PYPD 2
- CVR 0
- Target Price
- PYPD $10.50
- CVR N/A
- AVG Volume (30 Days)
- PYPD 49.0K
- CVR 1.3K
- Earning Date
- PYPD 02-12-2025
- CVR 11-12-2024
- Dividend Yield
- PYPD N/A
- CVR 2.13%
- EPS Growth
- PYPD N/A
- CVR N/A
- EPS
- PYPD N/A
- CVR N/A
- Revenue
- PYPD N/A
- CVR $29,663,473.00
- Revenue This Year
- PYPD N/A
- CVR N/A
- Revenue Next Year
- PYPD N/A
- CVR N/A
- P/E Ratio
- PYPD N/A
- CVR N/A
- Revenue Growth
- PYPD N/A
- CVR N/A
- 52 Week Low
- PYPD $2.37
- CVR $13.81
- 52 Week High
- PYPD $7.00
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- PYPD 55.20
- CVR 41.34
- Support Level
- PYPD $2.93
- CVR $15.55
- Resistance Level
- PYPD $3.35
- CVR $15.94
- Average True Range (ATR)
- PYPD 0.24
- CVR 0.22
- MACD
- PYPD 0.04
- CVR 0.06
- Stochastic Oscillator
- PYPD 93.15
- CVR 14.14
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.